GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Functional Bloating / Distension
Functional GI

Functional Bloating / Distension

Rome IV — bloating without other bowel disorder criteria

Mild pain related to the bloating and minor bowel movement abnormalities are permitted — what matters is that bloating is the dominant complaint.

Four exclusions in one criterion. Postprandial distress syndrome is a gastroduodenal disorder, so this requires looking outside the bowel chapter.

Bloating or distension must PREDOMINATE over other symptoms, and four other bowel disorders must be excluded — including postprandial distress syndrome, which sits in a different Rome IV chapter.

When to use
Use it when bloating or visible distension is the patient's leading complaint rather than an accompaniment to pain or altered bowel habit. That distinction is the whole point of the category: bloating is a symptom of almost every functional gastrointestinal disorder, and this diagnosis is reserved for the minority in whom it is the problem rather than a feature. Working through the four exclusions is the substance of applying these criteria, and it requires stepping outside the bowel chapter to check postprandial distress syndrome.
Why use it
Because bloating is one of the most common and least well-handled gastrointestinal complaints, and the default response — simethicone, dietary restriction and reassurance — reflects the absence of a framework rather than the absence of options. Separating bloating from distension is the first useful step, since they overlap but are not the same: bloating is the sensation, distension the measurable increase in girth, and a patient with visible distension may have abdomino-phrenic dyssynergia, which is a demonstrable motor abnormality amenable to biofeedback. Naming the disorder also stops bloating being treated as a lesser symptom of something else when it is the thing the patient actually wants addressed.
Formula, evidence and interpretation

About the Rome IV Criteria for Functional Abdominal Bloating/Distension

Predominates is the word that does the work. Rome IV requires recurrent bloating and/or distension on average at least one day a week, with bloating or distension *predominating over other symptoms* — and then requires that criteria are insufficient for four other disorders: irritable bowel syndrome, functional constipation, functional diarrhoea and postprandial distress syndrome. That last one sits in a different Rome IV chapter, which is why it is the exclusion most often skipped. Mild pain related to the bloating and minor bowel habit changes are explicitly permitted.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Functional bloating = timing AND (bloating/distension ≥ 1 day/week AND predominating) AND NOT IBS AND NOT functional constipation AND NOT functional diarrhoea AND NOT PDS
Predominating
The criterion that makes this a distinct disorder rather than a symptom of the others. Bloating accompanying pain or altered bowel habit does not qualify.
Four exclusions
IBS, functional constipation and functional diarrhoea are in the bowel chapter; postprandial distress syndrome is in the gastroduodenal chapter.
  • Mild pain related to the bloating is permitted, as are minor bowel movement abnormalities. Rome IV states this explicitly.
  • 'And/or' — bloating alone, distension alone, or both, all satisfy the symptom criterion.
  • At least one day a week is a lower frequency bar than most Rome IV bowel disorders apply.
  • The postprandial distress syndrome exclusion crosses chapters, and is the one most often missed.

Interpreting the result

Meeting the criteria should prompt three lines of thought. First, distinguish bloating from distension by asking whether the abdomen visibly enlarges and whether clothing becomes tight — that separates a sensory problem from a motor one, and visible distension makes abdomino-phrenic dyssynergia worth considering, with biofeedback as the intervention. Second, consider carbohydrate malabsorption and small intestinal bacterial overgrowth where the history fits, recognising that the evidence for testing and treating the latter is contested. Third, a low FODMAP diet has reasonable evidence but needs dietetic supervision and a structured reintroduction phase — an unsupervised elimination diet maintained indefinitely narrows the diet, risks nutritional inadequacy and alters the microbiome without benefit. Where criteria are not met, the reason is almost always that one of the four excluded disorders fits better, and treating that disorder usually improves the bloating as a consequence.

ScoreBandWhat it meansAction
All criteria metFunctional abdominal bloating/distensionBloating or distension at least weekly and predominating, with the four related disorders excludedSeparate bloating from distension; consider abdomino-phrenic dyssynergia, carbohydrate malabsorption and supervised dietary modification
One of the four disorders fits betterCriteria not metBloating accompanying pain, altered bowel habit or postprandial fullness belongs to that disorderTreat the fitting disorder — the bloating usually improves as a consequence
Bloating present but not predominantCriteria not metBloating is a supportive feature of most functional GI disorders rather than a diagnosis in itselfIdentify and address the dominant symptom

What the Functional Bloating / Distension needs (3 inputs)

Timing
Criteria fulfilled for the last three months with symptom onset at least six months before diagnosis.
Recurrent bloating and/or distension at least 1 day a week, predominating over other symptoms
Both the frequency and the predominance matter. Rome IV explicitly permits mild pain related to the bloating and minor bowel movement abnormalities — what it does not permit is those features dominating.
Insufficient criteria for IBS, functional constipation, functional diarrhoea or postprandial distress syndrome
Four exclusions bundled into one criterion. Postprandial distress syndrome is a gastroduodenal disorder, so satisfying this requires checking a different Rome IV chapter — it is the one most often overlooked.

What it returns

Criteria met or not met
Requires the timing rule, the predominance criterion and all four exclusions.
Which criterion remains outstanding
Named explicitly. A failure on the exclusions usually means another functional disorder is the better fit rather than that nothing is wrong.

How it is calculated

Bloating and distension are treated together in the criteria but are physiologically distinct, and understanding that separation is what makes the diagnosis useful. Bloating is a subjective sensation of abdominal fullness or pressure, closely linked to visceral hypersensitivity. Distension is an objective increase in abdominal girth, and a substantial proportion of it is not caused by increased intra-abdominal volume at all but by abdomino-phrenic dyssynergia — a paradoxical response in which the diaphragm descends and the anterior abdominal wall relaxes, redistributing normal gas volume outward. That mechanism is demonstrable on imaging and electromyography and is correctable with biofeedback. Rome IV's decision to define the disorder by predominance rather than by mechanism reflects the state of the evidence: the symptom is common, the mechanisms are several, and the category identifies who warrants looking into them rather than specifying which applies.

Facts & figures

Bloating and distension are not the same thing
BloatingDistension
NatureSubjective sensation of fullness or pressureObjective increase in abdominal girth
Main mechanismVisceral hypersensitivityOften abdomino-phrenic dyssynergia rather than increased gas volume
How to identifyPatient reportVisible enlargement; clothing becomes tight through the day
Targeted treatmentNeuromodulators, dietary modificationBiofeedback for abdomino-phrenic dyssynergia

They overlap but frequently occur separately, and the distinction changes what is worth trying. Asking whether the abdomen visibly enlarges takes seconds and is rarely asked.

The four exclusions, and where each lives
DisorderRome IV chapterDiscriminating feature
Irritable bowel syndromeBowelAbdominal pain related to defecation
Functional constipationBowelTwo or more constipation items
Functional diarrhoeaBowelLoose stools in > 25% of stools
Postprandial distress syndromeGastroduodenalPostprandial fullness or early satiation ≥ 3 days a week

Three are in the bowel chapter and one is not. Checking postprandial distress syndrome requires deliberately looking outside the disorder group, which is why it is the exclusion most often skipped.

Evidence

Derivation — Rome Foundation, bowel disorders committee

2016

Consensus criteria from the Rome IV bowel disorders committee, published in Gastroenterology in 2016.

Consensus-derived. Rome IV added the explicit requirement that bloating or distension predominate over other symptoms, and extended the exclusions to include postprandial distress syndrome from the gastroduodenal chapter.

Clinical practice update — AGA 2023

2023

AGA clinical practice update on the evaluation and management of belching, abdominal bloating and distension.

Sets out the separation of bloating from distension, the role of abdomino-phrenic dyssynergia in visible distension, and the evidence for dietary, behavioural and pharmacological management.

Guideline context — ACG irritable bowel syndrome

2021

ACG clinical guideline on the management of irritable bowel syndrome, which addresses bloating as a symptom within IBS and the evidence for a low FODMAP diet.

Supports a low FODMAP diet with dietetic supervision and a structured reintroduction phase, rather than indefinite unsupervised restriction.

How it compares

Functional Bloating / Distension vs Rome IV criteria for IBS

Mutually exclusive — bloating is a supportive feature of IBS, and only becomes this diagnosis when it predominates and IBS criteria are not met.

The great majority of patients with IBS report bloating, so the symptom alone does not distinguish them. Rome IV resolves this by requiring that bloating predominate and that IBS criteria be insufficient — meaning no recurrent abdominal pain related to defecation or to a change in stool frequency or form. In practice, most patients presenting with bloating turn out to have IBS, and treating the IBS improves the bloating. Functional abdominal bloating is the smaller residual group in whom that pathway does not apply, and the practical consequence is that IBS-directed therapy is not the obvious first move.

Open the Rome IV criteria for IBS calculator →

Functional Bloating / Distension vs Postprandial distress syndrome

The cross-chapter exclusion — bloating that follows meals alongside early satiation is a gastroduodenal problem, not a bowel one.

Rome IV lists epigastric bloating among the supportive features of postprandial distress syndrome, and requires PDS to be excluded before functional abdominal bloating can be diagnosed. The discriminating features are timing and location: PDS bloating is postprandial and epigastric, accompanied by fullness or early satiation at least three days a week, while functional bloating is more diffuse and less tightly meal-related. Because the two sit in different chapters, checking this exclusion requires a deliberate step outside the bowel disorders, and it is the one most often omitted.

Open the Postprandial distress syndrome calculator →

Functional Bloating / Distension vs Small intestinal bacterial overgrowth

A frequently invoked and genuinely contested alternative — breath testing has poor specificity, and a positive result does not reliably predict response to antibiotics.

SIBO is commonly proposed as the explanation for functional bloating, and breath testing is widely used, but the evidence base is weaker than the enthusiasm suggests: glucose and lactulose breath tests have limited specificity, they are affected by transit time, and symptom improvement after antibiotics correlates poorly with baseline results. It is a reasonable consideration where there is a predisposing anatomical or motility abnormality — previous surgery, strictures, scleroderma, or documented slow transit — and much weaker as a routine explanation for isolated bloating. Repeated antibiotic courses on the basis of breath tests is a common pattern with a thin justification.

Moshiree B, Drossman D, Shaukat A. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review. Gastroenterology. 2023;165(3):791-800.

Pearls & pitfalls

  • Predominance is the criterion that makes this a diagnosis rather than a symptom. Bloating accompanying pain or altered bowel habit belongs to the disorder it accompanies.
  • Postprandial distress syndrome is in the gastroduodenal chapter and is the exclusion most often skipped. Bloating that follows meals with early satiation is probably PDS.
  • Ask whether the abdomen visibly enlarges. Distension and bloating are different problems with different treatments, and the question is rarely asked.
  • Visible distension raises abdomino-phrenic dyssynergia, which is a motor abnormality correctable with biofeedback rather than a gas problem.
  • Mild pain related to the bloating is explicitly permitted and does not exclude the diagnosis.
  • One day a week is a low frequency bar — lower than most of the Rome IV bowel disorders.
  • A low FODMAP diet needs dietetic supervision and a reintroduction phase. Indefinite unsupervised restriction narrows the diet and alters the microbiome without added benefit.
  • Simethicone and similar over-the-counter agents have little evidence and are what most patients have already tried before presenting.
  • New or progressive distension with weight loss, ascites or a mass is not this diagnosis and requires imaging.

Critical actions

  • Establish whether bloating predominates or merely accompanies other symptoms — that decides whether this is the right category.
  • Work through all four exclusions, including postprandial distress syndrome from the gastroduodenal chapter.
  • Ask specifically whether the abdomen visibly enlarges and whether clothing tightens through the day.
  • Consider abdomino-phrenic dyssynergia where distension is visible, and refer for biofeedback where available.
  • Consider carbohydrate malabsorption and, with appropriate scepticism about the evidence, small intestinal bacterial overgrowth.
  • Refer for dietetic-supervised low FODMAP with a structured reintroduction phase rather than advising self-directed elimination.
  • Exclude ascites, an abdominal mass and coeliac disease where distension is new, progressive or accompanied by weight loss.
  • Address any coexisting constipation, which worsens bloating and is frequently the more tractable target.

Why this score exists

The committee faced an awkward problem: bloating is reported by the majority of patients with any functional gastrointestinal disorder, so defining it as a disorder in its own right risks either capturing everyone or capturing no one. Their solution was predominance — the symptom has to be the main event, not an accompaniment — combined with a set of exclusions that deliberately reaches into another chapter. Adding postprandial distress syndrome to the exclusions is the interesting part, because it acknowledges that upper and lower gastrointestinal functional disorders overlap in this symptom and that a patient whose bloating follows meals may be describing a gastroduodenal problem. The permission for mild pain and minor bowel changes is equally deliberate: without it, almost nobody would qualify, since a completely isolated bloating symptom is rare.

About the creator

  • Brian E. Lacy

    First author, Rome IV bowel disorders committee

    Chaired the committee that produced the Rome IV functional bowel disorder criteria.

  • Magnus Simrén

    Co-author; visceral hypersensitivity and bloating

    Contributed to the physiological work underlying the separation of bloating from distension.

Limitations

  • 'Predominating' is a subjective judgement with no anchor, and patients weigh their symptoms differently from clinicians.
  • Requires four exclusions, one of which sits in a different Rome IV chapter and is routinely skipped.
  • Treats bloating and distension as a single entity despite their different mechanisms and different treatments.
  • Consensus criteria with no external validation, and 'predominant' is left to the clinician to judge rather than measured.
  • Says nothing about the mechanistic subgroups — gas handling, hypersensitivity, abdomino-phrenic dyssynergia — that determine what actually helps.
  • The one-day-a-week threshold is low, and captures a large population of whom only some are meaningfully impaired.
  • Offers no guidance on the role of breath testing or dietary intervention, both of which dominate practice.
  • Says nothing about severity, and bloating ranges from mildly annoying to socially disabling.

If you are the patient

Functional bloating means a feeling of being bloated, or a visible swelling of the abdomen, at least one day a week — and importantly, that this is your main problem rather than something that comes along with pain or a change in bowel habit. If tummy pain linked to opening your bowels is the bigger issue, the diagnosis is usually irritable bowel syndrome instead. One question worth asking yourself before your appointment is whether your abdomen actually gets visibly bigger through the day — whether waistbands become tight — or whether it just feels full. Those are two different problems. Visible swelling is often not caused by extra gas at all, but by the muscles of the abdominal wall and diaphragm working in an uncoordinated way that pushes the same amount of gas outwards. That has a specific treatment, a form of biofeedback that retrains the coordination, and it works well. On diet: a low FODMAP diet does help many people, but it should be done with a dietitian and must include a reintroduction phase where foods are added back. Staying on a restricted version long term narrows what you eat without extra benefit. Over-the-counter anti-gas remedies have little evidence behind them, which is worth knowing before spending money on them.

Frequently asked questions

What are the Rome IV criteria for functional abdominal bloating?#

Recurrent bloating and/or distension on average at least one day a week, with bloating or distension predominating over other symptoms; and insufficient criteria for IBS, functional constipation, functional diarrhoea or postprandial distress syndrome. Fulfilled for three months with onset at least six months earlier. Mild pain related to the bloating and minor bowel movement abnormalities are permitted.

What is the difference between bloating and distension?#

Bloating is the subjective sensation of fullness or pressure; distension is a measurable increase in abdominal girth. They overlap but frequently occur separately. The distinction matters because visible distension is often caused by abdomino-phrenic dyssynergia — the diaphragm descending and the abdominal wall relaxing, redistributing normal gas outward — which is correctable with biofeedback rather than being a gas problem.

Why is postprandial distress syndrome one of the exclusions?#

Because epigastric bloating is a supportive feature of it, and a patient whose bloating follows meals alongside early satiation is describing a gastroduodenal disorder rather than a bowel one. It sits in a different Rome IV chapter, which is precisely why it is the exclusion most often skipped when these criteria are applied.

Can you have bloating with IBS and still meet these criteria?#

No. Rome IV requires that IBS criteria are insufficient. Most patients with IBS report bloating, so the symptom alone does not distinguish them — the question is whether recurrent abdominal pain related to defecation or to a change in stool frequency or form is present. If it is, the diagnosis is IBS, and treating the IBS usually improves the bloating.

Does a low FODMAP diet help functional bloating?#

It has reasonable evidence, but it needs dietetic supervision and a structured reintroduction phase. An unsupervised elimination diet maintained indefinitely narrows the diet, risks nutritional inadequacy and alters the gut microbiome without additional benefit. The restriction phase is meant to be time-limited and diagnostic, followed by systematic reintroduction to identify the specific triggers.

Is small intestinal bacterial overgrowth the cause of bloating?#

Sometimes, but the evidence is weaker than its popularity suggests. Glucose and lactulose breath tests have limited specificity, are affected by transit time, and a positive result predicts response to antibiotics poorly. SIBO is a reasonable consideration where there is a predisposing anatomical or motility abnormality, and a much weaker explanation for isolated bloating in an otherwise normal gut.

When should bloating be investigated with imaging?#

When distension is new, progressive, or accompanied by weight loss, a palpable mass, or clinical signs of ascites. None of those is a feature of functional bloating, and the criteria should never be used to defer investigation of them. Coeliac disease is also worth excluding, since it presents with bloating regularly.

How often must bloating occur to meet the criteria?#

At least one day a week on average, over the last three months, with onset at least six months earlier. That is a lower frequency threshold than Rome IV applies to most bowel disorders, which means the frequency criterion is rarely the limiting factor — the predominance requirement and the four exclusions do most of the filtering.

Related calculators

  • Rome IV Criteria for IBS — Irritable bowel syndrome diagnosis and subtype
  • Functional Dyspepsia — Rome IV — with PDS and EPS subtyping
  • Functional Constipation — Rome IV — two of six items, IBS excluded
  • Belching Disorders — Rome IV — supragastric vs gastric belching
  • Bristol Stool Scale — Stool form types 1–7 and colonic transit
  • Unspecified Functional Bowel Disorder — Rome IV — bowel symptoms fitting no other category
  • Aerophagia — Rome IV — distension that increases through the day

References

Original / primary reference

  1. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;150(6):1393-1407 (Rome IV).

Clinical practice update

  1. Moshiree B, Drossman D, Shaukat A. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review. Gastroenterology. 2023;165(3):791-800.
  2. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44.

Last updated August 1, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.